Clinical trial
A Prospective Structural, Diffusion and Connectomics MRI Study on Migraine Patients Treated With Fremanezumab: The FreMRI Study
NCT06244823 is registered in ClinicalTrials.gov with Hospital Clínico Universitario de Valladolid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Structural, Diffusion and Connectomics MRI Study on Migraine Patients Treated With Fremanezumab: The FreMRI Study
- Lead sponsor
- Hospital Clínico Universitario de Valladolid
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 1, 2023
- Completion date
- January 1, 2025
- Enrollment
- 87 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.